Despite Covid, Rs 3.7k crore injected in Telangana life | Hyderabad News

HYDERABAD: Bharat Biotech International Limited CMD Krishna Ella said Hyderabad today accounts for nearly 65% of the global vaccine supply and “it is well equipped to play a key role in battling any health crisis that humanity faces in the future”. He was speaking after receiving the Genome Valley Excellence Award 2021 at the inaugural session of the BioAsia 2021 summit. The summit, organised by the Telangana government, is one of the largest gatherings on life sciences companies and academia in the country.
Speaking at the inauguration, Telangana IT and industries minister KT Rama Rao said that despite all the Covid-19 gloom and doom, the state’s life sciences sector attracted investments worth about Rs 3,700 crore in last one year. “This will create employment for about 14,000 people,” he added.
Lauding the efforts of Bharat Biotech in developing country’s first indigenously developed Covid-19 vaccine, Covaxin, KTR said that the work done by other homegrown vaccine players such as Biological E, Indian Immunologicals, among others, has helped the city make a significant contribution in the fight against Covid-19.
He pointed out that even pharma players such as Aurobindo Pharma, Dr Reddy’s and Hetero are doing their bit in this fight. While Hetero and Dr Reddy’s are trying to augment the global supply of vaccines by manufacturing and distributing Russian vaccine Sputnik V, Aurobindo is building a vaccine manufacturing facility with a capacity of about 450 million doses, he said.
KTR said the state government was working on various initiatives such as Digital Medicine Hub, Institute for Cell and Gene Therapy, Flow Chemistry Hub and a life sciences university, among others to boost the future prospects of the pharma and life sciences sector.
Naveen Gullapalli, global head, Novartis Business Services Innovation and Satish Reddy, chairman, Dr Reddy’s Laboratories, were among industry leaders present during the inaugural session.

Source link